Subscribe to MDT Magazine News

3M to acquire Cogent for about $933 million

August 30, 2010 4:45 am | by The Associated Press | Comments

Technology company 3M Co. says it has agreed to acquire Cogent Inc. in a deal worth about $933 million.Cogent, based in Pasadena, Calif., develops automated systems that read finger and palm prints.Cogent's board of directors has agreed to the deal, announced Monday, and is recommending that...

MedCath sells South Dakota hospital for $20M

August 30, 2010 4:45 am | by The Associated Press | Comments

MedCath will sell its stake in Avera Heart Hospital of South Dakota to Avera McKennan for $20 million, the healthcare provider said Monday.MedCath owns one-third of the hospital and management rights.After the sale, Avera McKennan will own two-thirds of Avera Heart. Avera McKennan is a member...

SQI Diagnostics says higher research costs increased third-quarter loss

August 30, 2010 3:45 am | by The Associated Press | Comments

SQI Diagnostics Inc. (TSXV:SQD) has reported a loss of $1.6 million for the third quarter as increased expenses weighed on its quarterly results.The Toronto-based medical systems company said Monday its losses were equal to five cents a share, for the three months ended June 30. That compared...


Covidien Completes Sale of Specialty Chemicals Business

August 30, 2010 3:33 am | by Covidien | Comments

DUBLIN, Aug 30, 2010 (BUSINESS WIRE) --Covidien (NYSE: COV), a leading global provider of healthcare products, today announced that it has completed the previously announced sale of its Specialty Chemicals business to an affiliate of New Mountain Capital, L.L.C. for a cash purchase price...


Covidien Completes Sale of Sleep Therapy Product Line

August 30, 2010 3:32 am | by Covidien | Comments

DUBLIN, Aug 30, 2010 (BUSINESS WIRE) --Covidien (NYSE: COV), a leading global provider of healthcare products, today announced that it has completed the previously announced sale of its Sleep Therapy continuous positive airway pressure (CPAP) and Bi-level products to PH Invest, a...


Why Betting on 3D?

August 30, 2010 2:32 am | by I-Micronews | Comments

The continuation of Moore?s Law appears less in doubt than ever. Companies such as Intel, ST, AMD (via GlobalFoundries) and IBM are testing FinFETS and ETSOI and work is being done on the back end to ensure that these new structures can be manufactured with sufficient yield, according to...

New genomic marker for tuberculosis may help identify patients who will develop the disease

August 29, 2010 10:31 pm | by EurekAlert | Comments

(Nationwide Children's Hospital) It may soon be possible to identify patients who will develop tuberculosis, as scientists have identified changes in the blood specific to the disease. These findings are from an international study published in the Aug. 19 issue of Nature and conducted by...


New Court Ruling Could Cripple Stem-Cell Research

August 29, 2010 8:31 pm | by Massachusetts Institute of Technology | Comments

Once again, federal funding restrictions cast uncertainty over the field.


Sanofi-aventis Announces Non-Binding Offer to Acquire Genzyme

August 29, 2010 1:31 pm | by Bio-Medicine.Org | Comments

PARIS, Aug. 29 /- Sanofi-aventis (EURONEXT: SAN and NYSE: SNY ) announced today that it has submitted a non-binding proposal to acquire Genzyme (Nasdaq: GENZ ) in an all-cash transaction valued at approximately $18.5 billion. Under the terms of the proposed acquisition, Genzyme...


McMaster study contradicts reports of problems with blood-thinner

August 29, 2010 7:32 am | by EurekAlert | Comments

(McMaster University) New findings by McMaster University researchers contradict earlier reports that people with a certain genetic make-up don't benefit from the blood-thinner clopidogrel, also known as Plavix.


Genetic Substudy Shows Fewer Major Cardiovascular Events With Ticagrelor (BRILINTA) Regardless of Relevant Genetic Variability in ACS Patients

August 29, 2010 7:31 am | by Bio-Medicine.Org | Comments

WILMINGTON, Del., Aug. 29 /- A new genetic substudy of PLATO (A Study of PLAT elet Inhibition and Patient O utcomes) showed that the effects on a combined primary endpoint of cardiovascular death, myocardial infarction, or stroke seen in Acute Coronary Syndromes (ACS) patients who...


Developmental gene-environment interactions: A model for psychosis

August 29, 2010 3:32 am | by EurekAlert | Comments

(European College of Neuropsychopharmacology) Recent research findings in psychiatry indicate that genes are likely to influence disorder mostly indirectly, via their impact upon physiological pathways, and work by increasing the likelihood of developing a psychiatric disorder,...


Schizophrenia and psychotic syndromes

August 29, 2010 2:31 am | by EurekAlert | Comments

(European College of Neuropsychopharmacology) Even today psychotic disorders remain highly stigmatized, and despite the young age of the patients and the long-term service dependence often are not prioritized in the agenda of public health.


Huge verdict shakes up nursing home industry

August 28, 2010 8:45 am | by PAUL ELIAS - Associated Press Writer - Associated Press | Comments

During Cindy Cool's almost daily visits to the nursing home, she would routinely find her Alzheimer's-suffering father wearing urine-soaked clothes.The Blue Lake, Calif. resident said it would take upwards of 20 minutes for the apparently short-handed staff of Eureka Healthcare and...

Lawmakers: Better 510(k) Process Key to Keeping Device Jobs in US

August 27, 2010 4:31 pm | by U.S. Food & Drug Administration | Comments

Trying to keep devicemakers, and the jobs they provide, in the U.S., two senators are urging the FDA to be more transparent and predictable in its review of 510(k)s.



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.